YTHDF1 and neoplasm: The inhibition of YTHDF1 results in the overexpression of the interferon‐gamma (IFN‐γ) receptor and activation of the JAK/STAT1 signaling pathways, which increase tumor cells’ sensitivity to the immune response.283